Home
- Questions About Raises, Shuttle Fees Top Administrators Forum
A UAMS Update article about Meet Your Administrator”
- Gruenwald Is New U.S. Citizen
Michael Gruenwald becomes U.S. citizen
- Gruenwald Is New U.S. Citizen
Michael Gruenwald becomes U.S. citizen
- Doughnut Sale to Help UAMS Psychiatry Youth Program
A UAMS Update article about a bake sale
- Call-in Announcements, Forums Will Give Employees More Information
A UAMS Update article about plans to improve communication between administration and employees of UAMS Medical Center
- IT Help Desk 400,000th Call Sweepstakes
IT Help Desk 400,000th Call Sweepstates
- The UAMS Help Desk Today - Ten Years Later
The UAMS Help Desk Today - Ten Years Later
- Free Tickets for UAMS Nights at Ray Winder Field
A UAMS Update article about UAMS Night with the Travelers
- ARIA Training Sessions May 19 - June 27 at UAMS
A UAMS Update article about May 19 - June 27 training sessions
- Human Research Forum Is May 21
A UAMS Update article about human research Q & A
- Accolades, May 2003
Accolades to UAMS faculty and staff
- GCRC Deadline Changed to July 1 for Grant Proposals
A UAMS Update article about GCRC pilot grants
- History of the Help Desk
- Watch, Look & Listen: Preview of New UAMS Public Service Campaign
- Forum to Discuss Impact of HIPAA on Research
Update article about HIPAA and research at UAMS
- Human Research Q and A Forum June 27
A UAMS Update article about the human research forum
- Emailed Version of UAMS Notice of Privacy Practices
UAMS Notice of Privacy Practices
- Free UAF Symposium Aug. 14-15 on Evolution of Human Diet
A UAMS Update article about a diet symposium at UAF
- Tom Butler is Arkansas Administrator of the Year
Tom Butler of UAMS Is Arkansas Administrator of the Year
- Join the Prostate Cancer Race Walk. Click Here for Registration Form.*
Join the Prostate Cancer Race Walk. Click Here for Registration Form.
- Join the Prostate Cancer Race Walk. Click Here for Registration Form.*
Join the Prostate Cancer Race Walk. Click Here for Registration Form.
- Defense Department Funds Possible Therapeutic Vaccine for Ovarian Cancer at UAMS
Defense Department Funds Possible Therapeutic Vaccine for Ovarian Cancer at UAMS
- Defense Department Funds Possible Therapeutic Vaccine for Ovarian Cancer at UAMS
Defense Department Funds Possible Therapeutic Vaccine for Ovarian Cancer at UAMS
- Join UAMS/ACRC Team in Race for the Cure®!
Join UAMS/ACRC Team in Race for the Cure!
- Join UAMS/ACRC Team in Race for the Cure®!
Join UAMS/ACRC Team in Race for the Cure!
- UAMS Scientist Receives $272,000 Grant for Tailoring Cancer Treatments with Laser Test
UAMS Scientist Receives $272,000 Grant for Tailoring Cancer Treatments with Laser Test
- UAMS Scientist Receives $272,000 Grant for Tailoring Cancer Treatments with Laser Test
UAMS Scientist Receives $272,000 Grant for Tailoring Cancer Treatments with Laser Test
- Photo Album: Stephens Institute Was a Highlight of Medicine Alumni Reunion
Photo Album: Stephens Institute Was a Highlight of Medicine Alumni Reunion
- Kids First in Fort Smith Celebrated Fourth in Style
Kids First in Fort Smith Celebrated Fourth in Style
- Class of 1948 Dedicates Endowment to Excellence in Education
Class of 1948 Dedicates Endowment to Excellence in Education
- Pharmacy Professor Elected to American College of Clinical Pharmacy
Pharmacy Professor Elected to American College of Clinical Pharmacy
- Pharmaceutical Scientists, Graduate Students Meet at UAMS
Pharmaceutical Scientists, Graduate Students Meet at UAMS
- Stephanie Gardner, Pharm.D., Ed.D., Is Interim Dean of College of Pharmacy
Stephanie Gardner, Pharm.D., Ed.D., Is Interim Dean of College of Pharmacy
- New COPH Survey Research Expert Eager to Develop New Ways of Measuring Public Health
New COPH Survey Research Expert Eager to Develop New Ways of Measuring Public Health
- Ready, Set, Go! UAMS, KATV Launch Get Healthy Arkansas™
UAMS, KATV Launch Get Healthy Arkansas™
- Announcement from Dean Reece: Susan León becomes Assistant Dean of Finance in the College of Medicine
Announcement from Dean Reece: Susan León to be Assistant Dean of Finance in the College of Medicine
- Announcement from Dean Reece: Susan León becomes Assistant Dean of Finance in the College of Medicine
Announcement from Dean Reece: Susan León to be Assistant Dean of Finance in the College of Medicine
- Announcement from Dean Reece: Susan León becomes Assistant Dean of Finance in the College of Medicine
Announcement from Dean Reece: Susan León to be Assistant Dean of Finance in the College of Medicine
- UAMS Online Has New Search Engine
UAMS ONLINE has new search engine
- UAMS Online Has New Search Engine
UAMS ONLINE has new search engine
- UAMS Online Has New Search Engine
UAMS ONLINE has new search engine
- UAMS Staff Take on Different Duties in Iraq
UAMS Staff Take on Different Duties in Iraq
- UAMS Staff Take on Different Duties in Iraq
UAMS Staff Take on Different Duties in Iraq
- Putting a Face on UAMS the Focus of Ad Campaign
Putting a Face on UAMS the Focus of Ad Campaign
- Putting a Face on UAMS the Focus of Ad Campaign
Putting a Face on UAMS the Focus of Ad Campaign
- Putting a Face on UAMS the Focus of Ad Campaign
Putting a Face on UAMS the Focus of Ad Campaign
- THE HEROES AMONG US
The Arkansas Cancer Research Center is proud to support Lance Armstrong in his quest for an unprecedented
seventh Tour de France victory. Regardless of the outcome of this year's race, Lance has already won the respect and admiration of millions of cancer survivors around the world who see him as more than a championship athlete, they see him as one of them. The ACRC is looking for stories of heroes, people who have taken on cancer and beaten it. If you or someone you know has a story about their encounters with cancer and would like to share it with others, please send it to us (see flip side). Some of those stories will be published. Write today. Just because you've never worn a yellow jersey doesn't mean you aren't a hero.
- THE HEROES AMONG US
The Arkansas Cancer Research Center is proud to support Lance Armstrong in his quest for an unprecedented
seventh Tour de France victory. Regardless of the outcome of this year's race, Lance has already won the respect and admiration of millions of cancer survivors around the world who see him as more than a championship athlete, they see him as one of them. The ACRC is looking for stories of heroes, people who have taken on cancer and beaten it. If you or someone you know has a story about their encounters with cancer and would like to share it with others, please send it to us (see flip side). Some of those stories will be published. Write today. Just because you've never worn a yellow jersey doesn't mean you aren't a hero.
- Dr. David Broadcasts Weekly Medical Radio Show Live from UAMS
Dr. David Broadcasts Weekly Medical Radio Show Live from UAMS
- Dr. David Broadcasts Weekly Medical Radio Show Live from UAMS
Dr. David Broadcasts Weekly Medical Radio Show Live from UAMS
- Klimberg Named Inaugural Chair in Breast Surgical Oncology
Klimberg Named Inaugural Chair in Breast Surgical Oncology
Klimberg Named Inaugural Chair in Breast Surgical Oncology
Klimberg Named Inaugural Chair in Breast Surgical Oncology
Klimberg Named Inaugural Chair in Breast Surgical Oncology
- Klimberg Named Inaugural Chair in Breast Surgical Oncology
Klimberg Named Inaugural Chair in Breast Surgical Oncology
Klimberg Named Inaugural Chair in Breast Surgical Oncology
Klimberg Named Inaugural Chair in Breast Surgical Oncology
Klimberg Named Inaugural Chair in Breast Surgical Oncology
- Klimberg Named Inaugural Chair in Breast Surgical Oncology
Klimberg Named Inaugural Chair in Breast Surgical Oncology
Klimberg Named Inaugural Chair in Breast Surgical Oncology
Klimberg Named Inaugural Chair in Breast Surgical Oncology
Klimberg Named Inaugural Chair in Breast Surgical Oncology
- Klimberg Named Inaugural Chair in Breast Surgical Oncology
Klimberg Named Inaugural Chair in Breast Surgical Oncology
Klimberg Named Inaugural Chair in Breast Surgical Oncology
Klimberg Named Inaugural Chair in Breast Surgical Oncology
Klimberg Named Inaugural Chair in Breast Surgical Oncology
- Klimberg Named Inaugural Chair in Breast Surgical Oncology
Klimberg Named Inaugural Chair in Breast Surgical Oncology
Klimberg Named Inaugural Chair in Breast Surgical Oncology
Klimberg Named Inaugural Chair in Breast Surgical Oncology
Klimberg Named Inaugural Chair in Breast Surgical Oncology
- Klimberg Named Inaugural Chair in Breast Surgical Oncology
Klimberg Named Inaugural Chair in Breast Surgical Oncology
Klimberg Named Inaugural Chair in Breast Surgical Oncology
Klimberg Named Inaugural Chair in Breast Surgical Oncology
Klimberg Named Inaugural Chair in Breast Surgical Oncology
- Two UAMS Nurses Recognized Among Arkansas’ Best
Two UAMS Nurses Recognized Among Arkansas’ Best
- UAMS Brings Together Resources for Grieving Parents
A program developed by a group of UAMS nurses and other caregivers is reaching out to parents dealing with the loss of a baby.
- Novel plasma biomarker and marker profiles for analysis of metastatic disease: A unique fragment of parathyroid hormone related protein predicts breast metastasis to bone (11-09)
Novel biomarker profile for the management of metastisis to bone of patients with breast cancer.
- Novel plasma biomarker and marker profiles for analysis of metastatic disease: A unique fragment of parathyroid hormone related protein predicts breast metastasis to bone (11-09)
Novel biomarker profile for the management of metastisis to bone of patients with breast cancer.
- Novel plasma biomarker and marker profiles for analysis of metastatic disease: A unique fragment of parathyroid hormone related protein predicts breast metastasis to bone (11-09)
Novel biomarker profile for the management of metastisis to bone of patients with breast cancer.
- Gray’s Anomaly: A Source of Empowerment
Feb. 8, 2012 | “I’ll trim it so it’s not so bulky,” James Y. Suen, M.D., said as he folded, then snipped a tiny edge of gauze off before he placed it on his patient’s right jaw. He has cared for 23-year-old Jasmine Gray ever since she was 11 when she traveled from Memphis, Tenn. to see him after first being misdiagnosed.
- Need Something Sweet for Your Valentine?
Need Something Sweet for Your Valentine?
- Need Something Sweet for Your Valentine?
Need Something Sweet for Your Valentine?
- Code Moo Now Open
Code Moo Now Open
- Code Moo Now Open
Code Moo Now Open
- Sign Up for the UAMS House of Delegates Relay for Life Team
UAMS House of Delegates Relay for Life Team
- Sign Up for the UAMS House of Delegates Relay for Life Team
UAMS House of Delegates Relay for Life Team
- Overwhelming Response to SmartCare
Overwhelming Response to SmartCare
- Overwhelming Response to SmartCare
Overwhelming Response to SmartCare
- Celebrating African American Women Firsts
Celebrating African American Women Firsts
- Celebrating African American Women Firsts
Celebrating African American Women Firsts
- Nutrition Department Hosts Food Drive
Nutrition Department Hosts Food Drive
- Nutrition Department Hosts Food Drive
Nutrition Department Hosts Food Drive
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. 11-11
Treatment of cardiovascular diseases, heart attack and stroke remain leading causes of death in the world, affecting close to 15 million individuals per year. Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. 11-11
Treatment of cardiovascular diseases, heart attack and stroke remain leading causes of death in the world, affecting close to 15 million individuals per year. Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. 11-11
Treatment of cardiovascular diseases, heart attack and stroke remain leading causes of death in the world, affecting close to 15 million individuals per year. Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
The present invention is a method of in vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. The Photo Acoustic technique based on detection of laser−induced acoustic waves provides greater sensitivity and spatial resolution in deeper tissue compared to the other optical modalities. In vivo multicolor flow cytometry, negative and positive PA contrasts integrated with focused ultrasound has potential for dynamic study of various clots directly in the bloodstream of superficial microvessels associated with different diseases (e.g., cardiovascular disorder, cancer metastasis, or infection) and their treatment (e.g., stents, implants, drugs) which otherwise could not be detected with existing techniques.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
The present invention is a method of in vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. The Photo Acoustic technique based on detection of laser−induced acoustic waves provides greater sensitivity and spatial resolution in deeper tissue compared to the other optical modalities. In vivo multicolor flow cytometry, negative and positive PA contrasts integrated with focused ultrasound has potential for dynamic study of various clots directly in the bloodstream of superficial microvessels associated with different diseases (e.g., cardiovascular disorder, cancer metastasis, or infection) and their treatment (e.g., stents, implants, drugs) which otherwise could not be detected with existing techniques.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
The present invention is a method of in vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. The Photo Acoustic technique based on detection of laser−induced acoustic waves provides greater sensitivity and spatial resolution in deeper tissue compared to the other optical modalities. In vivo multicolor flow cytometry, negative and positive PA contrasts integrated with focused ultrasound has potential for dynamic study of various clots directly in the bloodstream of superficial microvessels associated with different diseases (e.g., cardiovascular disorder, cancer metastasis, or infection) and their treatment (e.g., stents, implants, drugs) which otherwise could not be detected with existing techniques.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
The present invention is a method of in vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. The Photo Acoustic technique based on detection of laser−induced acoustic waves provides greater sensitivity and spatial resolution in deeper tissue compared to the other optical modalities. In vivo multicolor flow cytometry, negative and positive PA contrasts integrated with focused ultrasound has potential for dynamic study of various clots directly in the bloodstream of superficial microvessels associated with different diseases (e.g., cardiovascular disorder, cancer metastasis, or infection) and their treatment (e.g., stents, implants, drugs) which otherwise could not be detected with existing techniques.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
|
Double Vision may be a troubling eye disorder, but it’s also the clever theme for the Harvey and Bernice Jones Eye Institute’s 10-year anniversary party. On April 22, staff, supporters and donors of the institute will celebrate its 10 years of success at a party featuring Sen. Dale Bumpers as the keynote speaker.
“Double Vision” was chosen as the theme for the party because two extraordinary women will be honored at the party. Those women – whose generous donations and visions helped make the institute what it is today – are the late Bernice Jones, whose original gift helped build the facility in 1993, and Pat Walker, who has given the institute large gifts to change the name of the Arkansas Center for Eye Research to the Pat & Willard Walker Eye Research Center and to add floors to the present building.
The Jones Eye Institute, a Center of Excellence at UAMS, was officially dedicated on April 8, 1994. This four-story, 50,000 square-foot facility houses the Department of Ophthalmology, the Pat & Willard Walker Eye Research Center, a chapel, a state-of-the-art eye clinic, a library, an auditorium, administrative and faculty offices and the Arkansas Lions Eye Bank and Laboratory – Arkansas’ only eye bank. The institute’s main mission is to fight blindness in Arkansas through patient care, education and research.
John P. Shock, M.D., director of the Jones Eye Institute and professor and chairman of the Department of Ophthalmology in the UAMS College of Medicine, joined the ophthalmology department 25 years ago and remembers its humble beginnings.
“There was only one full-time faculty member in the department, and the offices were located in an old chemistry laboratory,” Shock said. “Now, we have a staff of nearly 70 people and 16 full-time faculty members. Any success that we have experienced is due to our very strong and loyal staff and faculty, a wonderful advisory board and hundreds of donors led by Mrs. Bernice Jones and Mrs. Pat Walker.”
Shock said the annual patient visits to the institute now exceed 20,000 – a significant increase from 6,900 patient visits in 1980. The newest addition to the institute, he said, is the Department of Ophthalmic Technologies, where students can obtain a bachelor’s of science degree in ophthalmic technology and are eligible to become certified ophthalmic medical technologists.
Looking toward the next 10 years, Shock has plenty of goals for the Jones Eye Institute. Some of these goals include adding five floors to the facility and establishing a larger endowment. Shock said he also would like to bring in more specialists – two for each ophthalmic specialty – and continue to make the education and research programs even stronger.
|